Moderate Primary Open-Angle Glaucoma

The supraciliary drainage implant Miniject can safely and effectively treat mild to moderate glaucoma as a standalone procedure, according to a study published in the American Journal of Ophthalmology.

ViaLase completed enrollment in the VIA-002 pivotal trial investigating femtosecond laser image-guided high-precision trabeculotomy for the treatment of primary open-angle glaucoma, according to a press release.

PARIS — The HORIZON trial at 3 years demonstrated that the Hydrus Schlemm’s canal stent added sustained IOP lowering to that achieved by cataract surgery alone, Gus Gazzard, MD, MBBChir, FRCOphth, said at the European Society of Cataract and Refractive Surgeons meeting.